Beilstein J. Org. Chem. 2015, 11, 1886–1892.
terials and reagents were purchased from commercial sources (E)-N-Allyl-N-(4-bromobut-2-en-1-yl)-2,4-dinitroaniline
and used without further purification. HPLC grade solvents (15). To a solution of N-allyl-2,4-dinitroaniline (14, 400 mg,
were used if not mentioned otherwise. For the fluorescence 1.79 mmol, 1.00 equiv) in dry DMF (7 mL), NaH (60% in
measurements, a TECAN Infinite M1000 platereader was used. mineral oil, 143 mg, 3.58 mmol, 2.00 equiv) and (E)-1,4-
dibromobut-2-ene (1.53 g, 7.16 mmol, 4.00 equiv) were added.
N-Allyl-5-methoxynaphthalene-1-sulfonamide (12). To a The mixture was stirred at 70 °C for 16 h. The mixture was
DMF solution (30 mL) of sodium 5-methoxynaphthalene-1- diluted with EtOAc (50 mL), washed with water (2 × 50 mL)
sulfonate (11, 1.30 g, 5.00 mmol, 1.00 equiv), cooled on an ice and dried over MgSO4. The solvent was removed under vacuum
bath, thionyl chloride (1.09 mL, 15.0 mmol, 3.00 equiv) was and the residue was purified by flash column chromatography
added dropwise. After the complete addition, the ice bath was (silica gel, cyclohexane/EtOAc 5:1) to obtain 300 mg of red oil
removed and the reaction was stirred at rt for 3 h. Then, it was (47%). 1H NMR (400 MHz, CDCl3) δ 8.66 (d, 4JHH = 2.7 Hz,
poured onto 300 mL of ice water and extracted with ethyl 1H), 8.21 (dd, 3JHH = 9.4 Hz, 4JHH = 2.7 Hz, 1H), 7.09 (d, 3JHH
acetate (3 × 100 mL). The combined extracts were dried over = 9.4 Hz, 1H), 5.99–5.87 (m, 1H), 5.86–5.70 (m, 2H), 5.33 (d,
MgSO4 and the solvent was removed at reduced pressure. The 3JHH = 10.3 Hz, 1H), 5.28 (d, 3JHH = 17.2 Hz, 1H), 3.86–3.90
residual oil was taken up into DCM (100 mL). Allylamine was (m, 6H); 13C NMR (100 MHz, CDCl3) δ 148.1, 137.9, 137.7,
slowly added to the solution, while stirring. After complete ad- 131.8, 131.3, 128.4, 127.7, 123.7, 120.1, 119.4, 54.6, 53.2,
dition, the reaction mixture was allowed to stir overnight. The 31.0; HRMS [ESI(+)–TOF] m/z: [M + H]+ calcd for
solvent was removed under vacuum and the residue was puri- C13H15BrN3O4, 356.0246; found, 356.0239.
fied by flash column chromatography (silica gel, cyclohexane/
EtOAc 1:1) to obtain a colourless solid (893 mg, 64%). Substrate 5. A round bottom flask was charged with N-allyl-5-
1
H NMR (400 MHz, CDCl3) δ 8.46 (d, 3JHH = 8.4 Hz, 1H), methoxynaphthalene-1-sulfonamide (12, 449 mg, 1.62 mmol,
.22 (d, 3JHH = 8.7 Hz, 1H), 8.15 (s, 1H), 8.14 (d, 3JHH = 7.3 1.00 equiv), (E)-N-allyl-N-(4-bromobut-2-en-1-yl)-2,4-dini-
Hz, 1H), 7.66–7.58 (m, 2H), 7.13 (d, 3JHH = 7.6 Hz, 1H), 5.56 troaniline (15, 610 mg, 1.71 mmol, 1.06 equiv), K2CO3
8
(
(
(
(
ddt, 3JHH = 17.1 Hz, 3JHH = 10.3 Hz, 3JHH = 5.5 Hz, 1H), 5.05 (672 mg, 4.86 mmol, 3.00 equiv) and acetonitrile (20 mL). The
ddt, 3JHH = 17.1 Hz, 2JHH = 1.7 Hz, 4JHH = 1.7 Hz, 1H), 4.91 mixture was stirred at 70 °C overnight and filtered. The filtrate
ddt, 3JHH = 10.3 Hz, 2JHH = 1.5 Hz, 4JHH = 1.5 Hz, 1H), 4.01 was concentrated at reduced pressure and the residue was puri-
s, 3H), 3.45 (d, 3JHH = 5.5 Hz); 13C NMR (100 MHz, CDCl3) fied by flash column chromatography (silica gel, cyclohexane/
δ 155.1, 135.6, 134.2, 128.8, 128.6, 128.3, 126.9, 125.7, 123.8, EtOAc 3:1) to obtain 750 mg of an orange semi-solid (84%).
16.8, 116.2, 105.4, 55.9, 44.8; HRMS [ESI(+)–TOF] m/z: [M 1H NMR (400 MHz, CDCl3) δ 8.60 (d, 4JHH = 2.7 Hz, 1H),
H]+ calcd for C14H16NO3S, 278.0851; found, 278.0845; 8.52 (d, 3JHH = 8.4 Hz, 1H), 8.26 (dd, 3JHH = 7.4 Hz, 4JHH =
Elemental analysis: anal. calcd for C14H15NO3S: C, 60.63; H, 1.3 Hz, 1H), 8.14–8.08 (m, 2H), 7.55–7.46 (m, 2H), 6.94–6.86
.45; N, 5.05; found: C, 60.48; H, 5.58; N, 5.25. (m, 2H), 5.72–5.34 (m, 4H), 5.26 (d, 3JHH = 10.3 Hz, 1H), 5.17
d, 3JHH = 17.1 Hz, 1H), 5.14–5.05 (m, 2H), 4.03 (s, 3H), 3.86
1
+
5
(
N-Allyl-2,4-dinitroaniline (14). A flask was charged with 2,4- (dd, 3JHH = 17.7 Hz, 3JHH = 6.1 Hz, 4H), 3.74 (dd, 3JHH = 17.8
dinitrofluorobenzene (13, 854 mg, 4.59 mmol, 1.00 equiv) and Hz, 3JHH = 5.3 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 155.8,
THF (10 mL). First, triethylamine (710 µL, 5.05 mmol, 147.9, 137.6, 137.4, 134.3, 132.7, 131.4, 130.8, 129.9, 129.5,
1
1
.10 equiv) and then allylamine (378 µL, 5.05 mmol, 128.41, 128.39, 127.61, 127.55, 126.7, 123.6, 123.3, 120.0,
.10 equiv) was added and the mixture was stirred for 2 h at rt 119.3, 119.1, 116.8, 104.8, 55.7, 54.5, 53.2, 49.1, 47.1; HRMS
until the TLC showed complete consumption. The solvent was [ESI(+)–TOF]: [M + H]+ calcd for C27H29N4O7S, 553.1757;
removed under reduced pressure and the residue was purified found, 553.1756; Elemental analysis: anal. calcd for
by flash chromatography (silica gel, cyclohexane/EtOAc 3:1) to C27H28N4O7S: C, 58.69; H, 5.11; N, 10.14; found: C, 58.83; H,
obtain 960 mg of a yellow solid (94%). 1H NMR (400 MHz, 5.45; N, 10.15.
CDCl3) δ 9.15 (d, 4JHH = 2.7 Hz, 1H), 8.69 (bs, 1H), 8.27 (dd,
3
JHH = 9.5 Hz, 4JHH = 2.7 Hz, 1H), 6.92 (d, 3JHH = 9.5 Hz, Ring-closing metathesis in 96-well plates: To each well,
1
1
H), 5.96 (ddt, 3JHH = 17.3 Hz, 3JHH = 10.2 Hz, 3JHH = 5.1 Hz, 142 µL of the selected solvent (cooled at 5 °C to minimize
H), 5.39–5.30 (m, 1H), 4.13–4.08 (m, 1H); 13C NMR (100 evaporation) was pipetted. Then, 5 µL of a 3 mM precatalyst
MHz, CDCl3) δ 148.3, 136.4, 131.6, 130.6, 130.3, 124.2, 118.3, stock solution was added. Finally, 3 µL of the substrate stock
14.3, 45.7; HRMS [ESI(+)–TOF] m/z: [M + H]+calcd for solution was added (for the coumarin substrate 8 a 1 M stock
1
C9H10N3O4, 224.0671; found, 224.0663. Elemental analysis: solution was used, for the fluorophore quencher substrate 5, a
anal. calcd for C9H9N3O4: C, 48.43; H, 4.06; N, 18.83; found: 50 mM stock solution was used). The plate was then sealed with
C, 48.26; H, 4.15; N, 19.08.
transparent plastic foil and analyzed using a fluorescence plate
1891